Dr Michelle Perugini

About Michelle

Dr Michelle Perugini is an entrepreneur, academic, and internationally recognised expert in health, medical research, advanced analytics, and cognitive AI. The first 13 years of her career were spent in health and medical research, specialising in predictive genetics and translational medicine — leading complex projects that translated genetic mutation analysis and bioinformatics into clinical treatments for cancer patients, and pioneering new methods in proteomics that now drive drug discovery. That deep scientific foundation is what makes everything she has built since genuinely credible.

In 2007, Perugini co-founded ISD Analytics, where she led the research, development, and commercialisation of an award-winning human-population behaviour predictive analytics software product called Simulait. ISD Analytics was acquired by Ernst and Young in 2015 and became one of EY's global suite of analytics products. She is now co-founder and CEO of Presagen and its first product, Life Whisperer — a platform that uses artificial intelligence to better identify healthy embryos for IVF, with the goal of improving outcomes for couples wanting to have children. Presagen's model connects medical data from clinics globally through an online platform to co-develop medical AI products that can be delivered at scale and at low cost.

Perugini is a compelling speaker for health, technology, and innovation conferences where audiences want to understand what responsible, real-world AI commercialisation actually looks like. She brings a scientist's rigour and an entrepreneur's commercial instinct — a combination that is rare on any stage. For organisations exploring AI strategy, healthcare innovation, or the journey from research to scalable product, she offers a story that is both technically credible and deeply human in its purpose.